Hye Seung Lee

Seoul National University Hospital

Papers

1

Total Citations

12

H-Index

1

About

Dr. Hye Seung Lee is a leading surgical oncologist whose research centers on the molecular pathology of colorectal cancer and the advancement of minimally invasive liver surgery. Her most impactful work has focused on the prognostic significance of specific *KRAS* mutations in colorectal cancer, where she demonstrated that codon 12 mutations carry distinct prognostic value compared to codon 13 mutations—a finding with direct implications for personalized treatment strategies. This landmark study has garnered 12 citations since its 2023 publication, reflecting its immediate relevance to the field. Dr. Lee has also been instrumental in shaping the global conversation around robotic liver resection (RLR), contributing to international consensus statements that evaluate the benefits and limitations of this emerging technology. By bridging molecular oncology with surgical innovation, her work helps clinicians better stratify patient risk and refine surgical approaches. Her contributions are particularly valuable for researchers and surgeons seeking to integrate genetic profiling into operative decision-making, and her consensus-building efforts continue to guide best practices in hepatobiliary surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
12
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Different oncological features of colorectal cancer codon-specific <i>KRAS</i> mutations: Not codon 13 but codon 12 have prognostic value
12 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Seoul National University Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago